Perbedaan Cipta Sarana Medika Tbk. dan Chandra Asri Pacific Tbk.: Cipta Sarana Medika Tbk. diperdagangkan di Rp63 (kapitalisasi pasar 158,12 M, volume 24 jam 8,21 jt), sedangkan Chandra Asri Pacific Tbk. diperdagangkan di Rp1.910 (kapitalisasi pasar 162,64 T, volume 24 jam 293,21 jt). Perbedaan utamanya: Chandra Asri Pacific Tbk. jauh lebih besar — sekitar 1028,6× kapitalisasi pasar Cipta Sarana Medika Tbk., dan Chandra Asri Pacific Tbk. lebih aktif diperdagangkan (293,21 jt vs 8,21 jt). Mana yang lebih baik tergantung tujuan investasimu.
| DKHH | TPIA | |
|---|---|---|
Kapitalisasi Pasar | 158,12 M | 162,64 T |
Volume | 8,21 jt | 293,21 jt |
Lot | 82,15 rb | 2,93 jt |
Perputaran | 515,2 jt | 565 M |
Harga Rata-rata | 62,72 | 1.926,95 |
Nilai Transaksi | 515,2 jt | 565 M |
Harga Ekuilibrium Indikatif | 63 | 1.910 |
Volume Ekuilibrium Indikatif | 1,33 rb | 70,47 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Selengkapnya di halaman DKHH →PT Chandra Asri Petrochemical Tbk formerly PT. Tri Polyta Indonesia, Tbk (the Company) was established under the Domestic Capital Investment Law No. 6 year 1968 and Law No. 12 year 1970 by Notarial Deed No. 40 dated November 2, 1984 of Ridwan Suselo, S.H., notary public in Jakarta. The Company is the largest Indonesia producer of polypropyleneresins that are used in the manufacture of a wide range of consumer products.
Selengkapnya di halaman TPIA →